David Peloquin is a member of the firm’s health care group. He focuses his practice on advising academic medical centers, life sciences companies, and information technology companies on issues related to human subjects and animal research, data privacy, and Medicare/Medicaid and other third-party payor reimbursement issues. He frequently writes and speaks on topics related to each of these areas. In connection with the COVID-19 pandemic, David has also been providing guidance on a variety of privacy and regulatory issues related to development of diagnostic tests and mobile applications, research studies, and general health care compliance.
In addition to his advisory practice, David regularly works with members of the firm’s private equity group in conducting regulatory diligence of private equity investments in the clinical research space. He also collaborates with members of the firm’s litigation practice on government investigations involving the clinical research enterprise. Prior to attending law school, David worked as a project manager for a leading supplier of electronic medical records.